Combined fluorescence‐Raman spectroscopic setup for the diagnosis of melanocytic lesionsRiccardo Cicchi, Francesco S. Pavone, Alessandro Cosci et al.|Journal of Biophotonics|2013Cited by 54
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective studyMartina Dragotto, Emanuele Trovato, Alessandra Cartocci et al.|Journal of the European Academy of Dermatology and Venereology|2023Cited by 8
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areasAngela Michelucci, M. Romanelli, Flavia Manzo Margiotta et al.|Archives of Dermatological Research|2024Cited by 5
Early diagnosis for melanoma: Is open access to skin cancer clinics really significant? A prospective studyVincenzo De Giorgi, Torello Lotti, Alessia Gori et al.|Preventive Medicine|2010Cited by 5
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observationFlavia Manzo Margiotta, Francesca Prignano, Alessandra Michelucci et al.|Italian Journal of Dermatology and Venereology|2023Cited by 4